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Objective: Acute lower extremity ischemia secondary to arterial thromboembolism is a common problem. Contemporary
data regarding this problem are sparse. This report examines a 10-year single-center experience and describes the surgical
management and outcomes observed.
Methods: Procedural codes were used to identify consecutive patients treated surgically for acute lower extremity embo-
lization from January 2002 to September 2012. Patients presenting >7 days after onset of symptoms, occlusion of grafts/
stents, and cases secondary to trauma or iatrogenic injury were excluded. Data collected included demographics, medical
comorbidities, presenting clinical characteristics, procedural speciﬁcs, and postoperative outcomes. Results were evaluated
using descriptive statistics, product-limit survival analysis, and logistic regression multivariable modeling.
Results: The study sample included 170 patients (47% female). Mean age was 69.1 6 16.0 years. Of these, 82 patients
(49%) had a previous history of atrial ﬁbrillation, and four (2%) were therapeutically anticoagulated (international
normalized ratio $2.0) at presentation. Presentation for 83% was >6 hours after symptom onset, and 9% presented with a
concurrent acute stroke. Femoral artery exploration with embolectomy was the most common procedural management
and was used for aortic, iliac, and infrainguinal occlusion. Ten patients (6%) required bypass for limb salvage during the
initial operation. Local instillation of thrombolytic agents as an adjunct to embolectomy was used in 16%, fasciotomies
were performed in 39%, and unexpected return to the operating room occurred in 24%. Ninety-day amputation above or
below the knee was required during the index hospitalization in 26 patients (15%). In-hospital or 30-day mortality was
18%. Median (interquartile range) length of stay was 8 days (4, 16 days), and 36% of patients were discharged to a nursing
facility. Recurrent extremity embolization occurred in 23 patients (14%) at a median interval of 1.6 months. The 5-year
amputation freedom and survival estimates were 80% and 41%, respectively. Predictors of 90-day amputation included
prior vascular surgery, gangrene, and fasciotomy. Predictors of 30-day mortality included age, history of coronary artery
disease, prior vascular surgery, and concurrent stroke.
Conclusions: Despite advances in contemporary medical care, lower extremity arterial embolization remains a condition
that is associated with signiﬁcant morbidity and mortality. Furthermore, the condition is resource-intensive to treat and is
likely preventable (initially or in recurrence) in a substantial subset of patients. (J Vasc Surg 2014;60:702-7.)Thromboembolic disease leading to acute lower ex-
tremity ischemia is a common problem associated with
signiﬁcant morbidity and mortality.1-7 Embolectomy proce-
dures for embolic arterial occlusions of the lower extremities
are common, but contemporary data regarding themanage-
ment and expected outcomes are sparse. This study provides
a detailed report from a single center of acute lower extrem-
ity thromboembolism describing surgical management and
an assessment of outcomes. Considering improvements in
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METHODS
This study was conducted with approval from the Wake
Forest University Baptist Medical Center Institutional
Review Board. Patient consent was waived due to the
retrospective nature of this study.
Data collection, management, and case selection.
Patients undergoing lower extremity embolectomy of the
aorta, iliac, or infrainguinal arteries between January 2002
and September 2012 were identiﬁed from an operative
registry using Current Procedural Terminology (American
Medical Association, Chicago, Ill) codes 34201 and 34203
and selected for analysis. Using these codes, 245 patients
were identiﬁed. Cases due to trauma, iatrogenesis, occlu-
sion of a prior bypass graft or stent, as well as those patients
presenting with >7 days of symptoms were excluded from
further consideration.
This selection process resulted in a sample of 170
patients for analysis. Demographic, comorbidity, clinical
presentation, operative management, postoperative mor-
bidity, andmortality datawere abstracted from the electronic
medical record. In an effort to elucidate the severity of pre-
existing peripheral vascular disease, prior vascular surgery
Table I. Patient demographics and clinical characteristics
Variable No.
Frequency (%) or
mean 6 SD
Age, years 170 69.1 6 16.0
Female gender 170 80 (47)
Nonwhite race/ethnicity 169 33 (20)
Atrial ﬁbrillation 169 82 (49)
International normalized ratio $2 167 4 (2)
Hypertension 169 132 (78)
Smoking
Current 159 61 (38)
Ever 159 103 (65)
Coronary artery disase 169 63 (37)
Diabetes 169 55 (33)
COPD 169 23 (14)
End-stage renal disease 170 11 (6)
History of
Peripheral arterial disease 169 47 (28)
Vascular surgery 169 20 (12)
Lower extremity vascular surgery 169 12 (7)
Cancer 169 35 (21)
Stroke 169 30 (18)
Deep vein thrombosis 169 16 (9)
Heart valvular surgery 169 3 (2)
COPD, Chronic obstructive pulmonary disease; SD, standard deviation.
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ventions (including amputations). Rutherford’s classiﬁca-
tion8 was assigned using abstracted data from the history
and physical examination as well as the surgeon’s operative
note. The patient’s limb ischemia was categorized as
viable, I; marginally threatened, IIa; immediately threat-
ened, IIb; and irreversible, III.
Surgical treatment. Heparin anticoagulation was
generally started upon recognition of acute limb ischemia
and continued throughout the operation and postoperative
period. The initial revascularization attempt in all patients
was femoral or popliteal artery exposure and balloon cath-
eter thromboembolectomy. Our group preference is
femoral artery embolectomy as the initial approach in
most patients.
Intraoperative angiography was performed as needed
from the clinical assessment and at the discretion of the
operating surgeon, as was the performance of fasciotomy
and adjunct bypass procedures. The dictated results from
any intraoperative angiography performed were used to
deﬁne the presence of signiﬁcant peripheral arterial disease.
Amputations were recorded as occurring at the time of
initial operation, during the index admission, or after
discharge, and time to amputation was also recorded. Ma-
jor amputations were classiﬁed as transfemoral or transti-
bial. Minor amputations were considered any toe or
forefoot amputation and were not considered in the anal-
ysis of freedom from amputation.
Outcomes. Collected outcome data included 30-day
or in-hospital mortality, performance of amputation,
postoperative complications, and other adverse events. All
such data were obtained from the electronic medical re-
cord. Concurrent stroke was identiﬁed via the admission or
discharge summary and only recorded if the stroke was
classiﬁed as embolic. Recurrent embolization was deﬁned
as a discrete additional embolic event occurring in any
limb. Postoperative hemorrhage was deﬁned as a bleeding
event requiring surgical evacuation or transfusion of packed
red blood cells. Postoperative complications were consid-
ered signiﬁcant if they required additional intervention or
prolonged the hospital stay, or both. Acute kidney injury
was identiﬁed by the discharge summary. Length of stay
and discharge disposition (home, return to skilled facility,
new assignment to skilled facility) were also recorded.
Statistical analysis. Demographic, medical comorbid-
ity, presentation, operative management, postoperative
morbidity, and mortality data were examined using count
(%), median (interquartile range [IQR]), ormean6 standard
deviation. Freedom frommajor amputation and in-hospital
or 30-day mortality were evaluated using product-limit
survival analysis and multivariable logistic regression
modeling. Multivariable modeling was conducted using
forward model selection (P ¼ .10 to enter) with age
included in allmodels. Because of low event rates, a stopping
rule of ﬁve variables was implemented for model selection.
The candidate covariate list for both outcomes included
age, gender, race, hypertension, atrial ﬁbrillation, coronary
artery disease, smoking status, diabetes, history ofperipheral arterial disease, prior vascular surgery, cancer,
history of stroke, history of deep vein thrombosis, chronic
obstructive pulmonary disease, end-stage renal disease,
prior valvular heart surgery, international normalized ratio
$2, concurrent stroke, gangrene, days of symptoms, bilat-
eral procedure, and cardiac embolic source. The candidate
covariate list for amputation also included popliteal-only
cutdown, intraoperative lytics, fasciotomy, concurrent
bypass, and arteriogram.
Associations between the Rutherford classiﬁcation and
amputation and mortality outcomes were evaluated using
the Fisher exact test because complete evaluations of the
Rutherford classiﬁcation on all patients were not possible.
All statistical analyses were conducted using SAS 9.3 soft-
ware (SAS Institute, Cary, NC).RESULTS
Patient and presentation characteristics. We
analyzed 170 patients with acute thromboembolic lower ex-
tremity ischemia. Table I summarizes patient demographics
and clinical characteristics. Mean age was 69.1 6 16.0 years,
and 80 patients (47%) were female. Eighty-two patients
(49%) had a known diagnosis of atrial ﬁbrillation, but
only four patients at presentation demonstrated a warfarin-
associated international normalized ratio $2.0. Twenty-
three patients (17%) presented with <6 hours of symptoms.
The mean duration of symptoms before presentation was
1.7 6 1.4 days. Thirty-three patients (19%) demonstrated
thromboembolic occlusions affecting both lower extrem-
ities. During the index admission, 15 patients (9%) expe-
rienced a new, concurrent embolic stroke; of which, nine
strokes occurred before surgery, and six occurred after
Table II. Patient status according to the Rutherford
classiﬁcation
Rutherford
classiﬁcation
No. (%)
(N ¼ 139)
Amputations,
No. (%)
Mortality,
No. (%)
I 2 (1) 0 (0) 0 (0)
IIa 40 (29) 1 (3) 2 (5)
IIb 72 (52) 8 (11) 13 (19)
III 25 (18) 14 (56) 8 (32)
I, viable; IIa, marginally threatened; IIb, immediately threatened; and III,
irreversible.
Table III. Morbidity and mortality
Variable No. Frequency (%)
Amputation #90 days 170 27 (16)
Amputation type 170
Major 26 (15)
Minor 1 (1)
Mortality (30-day or in-hospital) 168 31 (18)
Recurrent embolization 168 23 (14)
Wound infection 170 36 (21)
Hemorrhage 170 29 (17)
Return to operating room 170
None 107 (63)
Planned return only 22 (13)
Any unplanned return 41 (24)
Amputation 10 (6)
Fasciotomy 7 (4)
Hematoma evacuation 13 (8)
Contralateral embolectomy 3 (2)
Incision and drainage or debridement 8 (5)
Other 7 (4)
Post-op infections other than wound 170 31 (18)
Pneumonia 15 (9)
Urinary tract infection 8 (5)
Bacteremia 6 (4)
Central catheter infection 4 (2)
Other 3 (2)
Major noninfectious post-op complications 170 71 (42)
Pulmonary failure 20 (12)
Acute renal failure 13 (8)
Cardiac 10 (6)
Myocardial infarction 11 (6)
Multiorgan system dysfunction 7 (4)
Ischemic bowel 3 (2)
Pulmonary embolism 2 (1)
Other 22 (13)
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survived.
Surgical management. Forty-nine percent of patients
were American Society of Anesthesiologists Physical Status
Classiﬁcation class 4 or 5. Common femoral artery expo-
sure for the performance of embolectomy was the initial
procedure in 86% of patients, and isolated popliteal fossa
exposure for the performance of embolectomy was used
in 16 (9%). Combination exposure of the femoral and
popliteal vessels to facilitate distal revascularization was
required in seven (4%). No direct tibial artery exposure
and embolectomy were identiﬁed in this series.
Intraoperative angiography was performed in 94 pa-
tients (55%), demonstrating concomitant atherosclerotic
peripheral arterial disease in 40 patients (43%). Intraopera-
tive thrombolysis was administered in 28 patients (16%)
because of incomplete distal arterial revascularization. Fas-
ciotomies were performed in 66 patients (39%), 63 at the
time of initial revascularization and three in a delayed
fashion. Thirteen patients (8%) required a bypass procedure
for persisting limb-threatening ischemia, with four ulti-
mately requiring major amputation. Ten bypass procedures
were performed concurrently with the initial
thromboembolectomy.
Thromboembolic disease causes. Clinically presumed
thromboembolic sources for the study sample were evalu-
ated. The most frequent source, in 88 patients (52%),
was cardiac, of which 41% were attributed to documented
atrial ﬁbrillation and 4% to other arrhythmias. The presence
of multiple potential sources was common, with 23
patients having at least two potential deﬁned sources. No
putative etiology was identiﬁed in 13 patients.
Rutherford classiﬁcation. The Rutherford classiﬁca-
tion for 139 examined patients is summarized in
Table II. Two patients heparinized at another institution
showed marked improvement in symptoms and signs of
ischemia in transit and were classiﬁed as I (1%). Fisher exact
test analysis showed a statistically signiﬁcant association
between the Rutherford class and amputation (P < .0001)
and death (P < .0286). Of the 25 patients classiﬁed as III
who did not die or require a known amputation, one patient
went to hospice, one patient’s family refused amputation,
and two were transferred and lost to follow-up.
Morbidity and mortality. Detailed morbidity and
mortality outcomes are listed on Table III. Patients
required 30 major amputations and three minoramputations; however, amputation within a 90-day in-
terval occurred in 27 patients (16%), with 26 (15%) being
major amputations. Median time to amputation was 1 day
(IQR, 0-6 days). Freedom from amputation was 80% at
5 years (Fig 1). The 30-day or in-hospital mortality was
18%. Estimated overall survival at 5 years was 41%
(Fig 2).
Additional, discrete embolization events occurred in
23 patients (14%). Median time to recurrent extremity
embolization was 1.6 months (IQR, 0.03-10.9 months),
and the most common site of recurrence was the contra-
lateral lower extremity in 12 patients. Ten recurrences
occurred in the index limb, and one in the upper ex-
tremity. Seven of the 23 patients with recurrent emboli-
zation underwent major amputations, three of whom
underwent bilateral major amputations. Upon recurrent
embolization, 11 of the 23 were not therapeutically anti-
coagulated, and coagulation status was unknown in
seven.
Forty-one patients (24%) patients returned to the oper-
ating room due to unplanned circumstances, most
commonly for hematoma evacuation (bleeding occurred
at the femoral exposure site in nine, fasciotomy site in
three). Wound complications occurred in 36 patients
(21%), and postoperative infections in 31 (18%). Major
Fig 1. The y axis shows the proportion who were free from
amputation, and the x axis shows the follow-up time in years. The
counts shown at the bottom represent the number remaining in
the analysis at the given time points.
Fig 2. The y axis shows the proportion who were alive and the x
axis shows the follow-up time in years. The counts shown at the
bottom represent the number remaining in the analysis at the given
time points.
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hospital stay occurred in 71 patients (42%).
Length of stay. The median total length of stay was
8 days (IQR, 4-16 days). Sixty patients (36%) were dis-
charged to a skilled nursing facility. Of these, 10 patients
returned to their prior nursing facility and 50 were new dis-
positions to skilled nursing care.
Multivariable analysis. Results of multivariable logis-
tic regression analyses of mortality and amputation are
summarized in Table IV. Statistically signiﬁcant pre-
dictors of amputation included prior vascular surgery,
gangrene, and fasciotomy. Predictors of death included
age, prior vascular surgery, and concurrent acute stroke.
DISCUSSION
This report details contemporary results of treating
acute lower extremity embolization from a single academic
medical center. In general, patients with acute lower
extremity ischemia secondary to embolization presented
in a delayed fashion and were most often treated with
balloon catheter embolectomy via an open femoral artery
exposure. Despite the relatively minimal physiologic tres-
pass of the procedure, the results demonstrated persistence
of signiﬁcant morbidity and mortality with a high resultant
demand for both in-hospital and postacute health care
resources.
Published outcomes associated with acute embolic
lower extremity ischemia include a 20-year multicenter
perspective reported by Tawes et al1 in 1985, which exam-
ined 739 patients (included patients singly treated with
anticoagulation). The amputation rate was 5%, mortalitywas 12%, and wound complications occurred in 19%. The
authors’ overall recommendation was to treat acute limb
ischemia patients aggressively, pursuing secondary opera-
tions as needed, and to administer anticoagulation
postoperativelydrecommendations that represent the cur-
rent standard of care.
Several additional studies were reported in the 1990s:
d Ljungman et al2 reported from a Swedish national
registry, performing a 19-year review involving 1190
patients and demonstrating a 5-year limb salvage rate
of 61% to 81% and a 5-year survival of 33% to 43%.
d Kuukasjärvi et al3 performed a retrospective, multi-
center study of 509 patients, citing a 30-day amputa-
tion rate of 16% and 30-day mortality of 13%.
d Davies et al4 performed the only prospective study,
published in 1997, detailing a 30-day amputation
rate of 6% and 16% mortality.
d Campbell et al5 examined records of 474 patients from
the United Kingdom and found a 30-day amputation
rate in 16% and a mortality rate of 22%.
Eliason et al6 more recently reported both a thor-
ough single-center study and an analysis of National
Inpatient Sample data and demonstrated similar ampu-
tation rates of 13% to 14% and mortality rates of 9%
to 12%. And ﬁnally in 2012, a review of 683 patients
by Dag et al7 from Turkey focused on risk factors
for amputation after arterial emboli and found an
amputation rate in 14% and an increased risk of ampu-
tation with a delay >6 hours from onset and recur-
rence of embolectomy.
Table IV. Multivariable analysis for in-house or 30-day mortality and 90-day amputationa
Covariate
30-day or in-hospital mortality Major amputation #90 days
OR (95% CI) P OR (95% CI) P
Age (1-year increment) 1.0 (1.00-1.09) .0321 1.0 (.93-1.01) .0941
Prior vascular surgery 9.2 (2.70-31.34) .0004 18.0 (4.73-68.71) <.0001
Coronary artery disease 2.3 (.87-5.97) .0948 . .
Concurrent stroke 12.4 (2.82-54.15) .0008 . .
Current smoker . . 0.2 (0.05-0.78) .0202
Gangrene . . 10.4 (1.12-95.96) .0396
Fasciotomy . . 6.0 (1.68-21.31) .0058
CI, conﬁdence interval; OR, odds ratio.
aEach model adjusts for all variables shown in the Table (except where noted by “.”). Age was included in each model regardless of signiﬁcance.
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outcomes for acute lower extremity arterial ischemia,
we believe our results provide a detailed and more
contemporary characterization of associated outcomes.
Unfortunately, morbidity and adverse event rates associ-
ated with this diagnosis remain formidable. Similar to the
data summarized previously, our observed 90-day major
amputation rate was 15%, and 30-day mortality rate was
18%. The 5-year estimated limb salvage was 80%, and
survival was 41%, comparable to those data reported
17 years earlier from the Swedish study by Ljungman
et al.2 A signiﬁcant rate of other morbidities was also
observed, with a prolonged median length of stay of
8 days, postoperative infections in 18%, wound infections
in 21%, and any unplanned return to the operating room
in 24%.
The features of our patient pool may explain the poor
outcomes demonstrated by this study, with 83% presenting
with symptoms of >6 hours. Not surprisingly, with this late
presentation, 70% of our patients (assessed by the Ruther-
ford classiﬁcation) had an immediately threatened limb or
an irreversible degree of acute limb ischemia. This delay
is likely a reﬂection of our catchment area, with a large pro-
portion of patients coming from neighboring states and
from remote distances.
Additional explanations may also account for the lack
of signiﬁcant improvement in outcomes over time associ-
ated with acute arterial thromboembolism. Given the
absence of major technical changes in the open surgical
procedures for arterial embolism, the lack of improvement
in outcomes possibly represents a relatively static mode of
open surgical management. Conversely, improvements in
medical management (including risk factor reduction and
critical care) and increases in catheter-based treatment of
this disease may offset any potential improvements by cor-
responding increases in the general level of patient
complexity and medical acuity.
In addition to an unyielding morbidity and mortality,
this analysis identiﬁed a high prevalence of subtherapeu-
tic anticoagulation among patients with a history of
dysrhythmia as a likely cause for almost half of the
observed cases. No other review has looked speciﬁcallyat whether patients with an indication for anticoagulation
presented with a therapeutic level of anticoagulation.
The observation that almost 50% of patients in this series
had a known diagnosis of atrial ﬁbrillation, but only four
people in the entire study were therapeutically anticoagu-
lated, identiﬁes a major potential target for preventive
efforts.
Furthermore, recurrent embolization occurred in 14%
of our study sample; Campbell et al9 showed in 2000 that
long-term anticoagulation reduced the risk of recurrent
limb ischemia. Although it is impossible to speculate
whether anticoagulation of those affected (who represent
frail patients at baseline) would have led to a set of hem-
orrhagic problems eclipsing the severity of issues posed by
their ischemia, we do believe that it represents a modiﬁ-
able risk factor as well as an area for focused prevention
efforts.
Short-term and long-term survival for the study sample
were both poor. This likely represents arterial thromboem-
bolism as a marker of advanced medical comorbidities and
chronic illness that signiﬁcantly limit survival independently
of the acute lower extremity ischemia. Affected patients
should be candidates for a comprehensive reassessment of
risk and application of primary and secondary preventive ef-
forts aimed at their chronic illnesses as well as being iden-
tiﬁed as individuals likely to beneﬁt from additional
rehabilitation and social support resources. These patients
would also likely represent a logical population to engage
in a proactive discussion of end-of-life and advanced direc-
tive issues, once recovered from their acute illness, to help
ensure that those issues are managed in accordance with
their wishes when they arise.
Several additional limitations of our study merit
speciﬁc discussion. The retrospective nature of the re-
view precluded complete data collection for all variables
and testing of any a priori hypotheses or management al-
gorithms. Also, the study sample originated from a sin-
gle center, capturing only a speciﬁc group of surgical
patients managed by a single specialty group with similar
management approaches. Furthermore, owing to the
difﬁculties in identifying patients treated in other fash-
ions, the sample only included those patients whose
JOURNAL OF VASCULAR SURGERY
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managed without an embolectomy were not assessed,
such as anticoagulation without revascularization,
thrombolysis, immediate amputation, bypass, or endo-
vascular revascularization, nor were patients captured
who decided to forgo surgery, such as those directed
to hospice.
CONCLUSIONS
This report details a large, single academic medical
center experience managing acute lower extremity
ischemia. The resultant data demonstrated that this prob-
lem remains a cause of high mortality, morbidity, and
health care resource use that may be preventable in a large
number of patients. The reported data also demonstrate
that the affected population represents a high-risk popula-
tion for near-term future death, representing an ideal
group for enhanced preventive efforts as health care sys-
tems continue to try to reduce the economic and human
consequences of repeated admissions for chronic disease
conditions.
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